Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease - PubMed (original) (raw)
Comparative Study
Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease
H Fai Poon et al. Neurobiol Dis. 2005 Apr.
Abstract
Parkinson's disease (PD) is the most common neurodegenerative movement disorder and is characterized by the loss of dopaminergic neurons in the substantia nigra compacta. alpha-Synuclein is strongly implicated in the pathophysiology of PD because aggregated alpha-synuclein accumulates in the brains of subjects with PD, mutations in alpha-synuclein cause familial PD, and overexpressing mutant human alpha-synuclein (A30P or A53T) causes degenerative disease in mice or drosophila. The pathophysiology of PD is poorly understood, but increasing evidence implicates mitochondrial dysfunction and oxidative stress. To understand how mutations in alpha-synuclein contribute to the pathophysiology of PD, we undertook a proteomic analysis of transgenic mice overexpressing A30P alpha-synuclein to investigate which proteins are oxidized. We observed more than twofold selective increases in specific carbonyl levels of three metabolic proteins in brains of symptomatic A30P alpha-synuclein mice: carbonic anhydrase 2 (Car2), alpha-enolase (Eno1), and lactate dehydrogenase 2 (Ldh2). Analysis of the activities of these proteins demonstrates decreased functions of these oxidatively modified proteins in brains from the A30P compared to control mice. Our findings suggest that proteins associated with impaired energy metabolism and mitochondria are particularly prone to oxidative stress associated with A30P-mutant alpha-synuclein.
Similar articles
- Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein.
Marxreiter F, Nuber S, Kandasamy M, Klucken J, Aigner R, Burgmayer R, Couillard-Despres S, Riess O, Winkler J, Winner B. Marxreiter F, et al. Eur J Neurosci. 2009 Mar;29(5):879-90. doi: 10.1111/j.1460-9568.2009.06641.x. Eur J Neurosci. 2009. PMID: 19291219 - Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein.
Frasier M, Walzer M, McCarthy L, Magnuson D, Lee JM, Haas C, Kahle P, Wolozin B. Frasier M, et al. Exp Neurol. 2005 Apr;192(2):274-87. doi: 10.1016/j.expneurol.2004.07.016. Exp Neurol. 2005. PMID: 15755545 - alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P. Lo Bianco C, et al. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10813-8. doi: 10.1073/pnas.152339799. Epub 2002 Jul 16. Proc Natl Acad Sci U S A. 2002. PMID: 12122208 Free PMC article. - Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?
Maguire-Zeiss KA, Short DW, Federoff HJ. Maguire-Zeiss KA, et al. Brain Res Mol Brain Res. 2005 Mar 24;134(1):18-23. doi: 10.1016/j.molbrainres.2004.09.014. Brain Res Mol Brain Res. 2005. PMID: 15790526 Review. - Gene dosage and pathogenesis of Parkinson's disease.
Eriksen JL, Przedborski S, Petrucelli L. Eriksen JL, et al. Trends Mol Med. 2005 Mar;11(3):91-6. doi: 10.1016/j.molmed.2005.01.001. Trends Mol Med. 2005. PMID: 15760766 Review.
Cited by
- Mitochondrial control of cell bioenergetics in Parkinson's disease.
Requejo-Aguilar R, Bolaños JP. Requejo-Aguilar R, et al. Free Radic Biol Med. 2016 Nov;100:123-137. doi: 10.1016/j.freeradbiomed.2016.04.012. Epub 2016 Apr 16. Free Radic Biol Med. 2016. PMID: 27091692 Free PMC article. Review. - Protein expression in a Drosophila model of Parkinson's disease.
Xun Z, Sowell RA, Kaufman TC, Clemmer DE. Xun Z, et al. J Proteome Res. 2007 Jan;6(1):348-57. doi: 10.1021/pr060488o. J Proteome Res. 2007. PMID: 17203978 Free PMC article. - A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP.
Kurz A, May C, Schmidt O, Müller T, Stephan C, Meyer HE, Gispert S, Auburger G, Marcus K. Kurz A, et al. J Neural Transm (Vienna). 2012 Mar;119(3):297-312. doi: 10.1007/s00702-011-0717-3. Epub 2011 Sep 30. J Neural Transm (Vienna). 2012. PMID: 21960009 Free PMC article. - Parkinson's disease and enhanced inflammatory response.
Stojkovska I, Wagner BM, Morrison BE. Stojkovska I, et al. Exp Biol Med (Maywood). 2015 Nov;240(11):1387-95. doi: 10.1177/1535370215576313. Epub 2015 Mar 13. Exp Biol Med (Maywood). 2015. PMID: 25769314 Free PMC article. Review. - Differential protection of black-seed oil on econucleotidase, cholinesterases and aminergic catabolizing enzyme in haloperidol-induced neuronal damage of male rats.
Akintunde JK, Irechukwu CA. Akintunde JK, et al. Ther Adv Drug Saf. 2016 Aug;7(4):132-46. doi: 10.1177/2042098616656812. Epub 2016 Jul 22. Ther Adv Drug Saf. 2016. PMID: 27493717 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous